Abstracts
Early Stages
-
T020: Interim PET-guided treatment of early-stage nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the GHSG HD16 and HD17 studies
Abstract Talk in Early Stages (Saturday 14:00–15:30)
View full abstract at Hemasphere…
- Dennis A. Eichenauer
- Ina Bühnen
- Michael Fuchs
- Richard Greil
- Alden Moccia
- Josée M. Zijlstra
- Sylvia Hartmann
- Carsten Kobe
- Markus Dietlein
- Andreas Engert
- Peter Borchmann
-
T021: Radiation-Free Therapy as the INitial treatment of Good-prognosis early non-bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET-2 - RAFTING Trial.
Abstract Talk in Early Stages (Saturday 14:00–15:30)
View full abstract at Hemasphere…
- Andrea Gallamini
- Marco Picardi
- Kateryna Filonenko
- Manuel Gotti
- Javier Núñez Céspedes
- Andrea Rossi
- Eva Domingo-Domènech
- Agnieszka Giza
- Roberto Sorasio
- Livio Trentin
- Mariana Bastos Oteiro
- Ewa Paszkiewicz-Kozik
- Ramon García Sanz
- Caterina Patti
- Stephane Chauvie
- Fabrizio Bergesio
- Luca Guerra
- Alessandro Rambaldi
- Ana Sureda Balari
- Jan Maciej Zaucha
-
T022: Sharing decisions regarding radiotherapy for Hodgkin lymphoma: a qualitative study of the experiences of patients and clinicians in the UK
Abstract Talk in Early Stages (Saturday 14:00–15:30)
View full abstract at Hemasphere…
- Rebecca Shakir
- Catriona Gilmour-Hamilton
- Craig Bakin
- Isabelle Gent
- Adam Holloway
- Alison Meeson
- Johanna Ramroth
- Georgios Ntentas
- David Cutter
- Michele Peters
-
P023: PET2-adapted approach after 2 cycles of ABVD is comparable to 2 cycles of BEACOPP escalated and 2 cycles of ABVD and irradiation in early unfavorable Hodgkin lymphoma
View full abstract at Hemasphere…
- Heidi Mocikova
- Jana Markova
- Lubica Gaherova
- Maria Maco
- Alice Sýkorová
- David Belada
- Marie Lukášová
- Vit Prochazka
- Juraj Duras
- Tomas Kozak
-
P024: Predictive Value of Baseline Metabolic Tumor Volume in Early-Stage Favorable Hodgkin Lymphoma – Data from the Prospective, Multicenter Phase III HD16 Trial
View full abstract at Hemasphere…
- Lutz van Heek
- Colin Stuka
- Helen Kaul
- Horst Müller
- Jasmin Mettler
- Felicitas Hitz
- Christian Baues
- Michael Fuchs
- Peter Borchmann
- Andreas Engert
- Markus Dietlein
- Conrad-Amadeus Voltin
- Carsten Kobe
-
P025: RADAR: An international phase III, PET response-adapted, randomised trial in progress, comparing ABVD±ISRT with brentuximab vedotin+AVD±ISRT in patients with previously untreated limited-stage classical Hodgkin lymphoma.
View full abstract at Hemasphere…
- John Radford
- Toyin Adedayo
- Arzhang Ardavan
- Sally F. Barrington
- Leanne Berkahn
- Stephane Chauvie
- Laura Clifton-Hadley
- Graham P. Collins
- Michael Crump
- David Cutter
- Darren Edwards
- Martin Hutchings
- Tim Illidge
- Amy A. Kirkwood
- Kim Linton
- Craig H. Moskowitz
- Pip Patrick
- Beth Phillips
- Lois Shepherd
- Sanne Tonino
- Judith Trotman
- Joanna Williams
- Nicole Wong Doo
Living beyond Lymphoma
-
T064: Doxorubicin exposure and breast cancer risk in adolescent and adult Hodgkin lymphoma survivors
Abstract Talk in Living beyond Lymphoma (Sunday 10:30–12:00)
View full abstract at Hemasphere…
- Suzanne I.M. Neppelenbroek
- Yvonne M.G. Geurts
- Berthe M. P. Aleman
- Cécile P.M. Janus
- Pieternella J. Lugtenburg
- Saskia E. Rademaker
- Roel J. de Weijer
- Maaike G.A. Schippers
- Bastiaan D.P. Ta
- Wouter J. Plattel
- Josée M. Zijlstra
- Richard W.M. van der Maazen
- Marten R. Nijziel
- Francisca Ong
- Erik C. Schimmel
- Eduardus F.M. Posthuma
- Marie José Kersten
- Lara H. Böhmer
- Karin Muller
- Harry R. Koene
- Liane C.J. te Boome
- Yavuz M. Bilgin
- Eva de Jongh
- Flora E. van Leeuwen
- Michael Schaapveld
-
T065: Reproduction patterns among Classical Hodgkin Lymphoma Survivors Treated with BEACOPP and ABVD in Sweden, Denmark, and Norway
Abstract Talk in Living beyond Lymphoma (Sunday 10:30–12:00)
View full abstract at Hemasphere…
- Joshua P. Entrop
- Caroline E. Weibull
- Karin E. Smedby
- Lasse Hjort Jakobsen
- Andreas K. Øvlisen
- Daniel Molin
- Ingrid Glimelius
- Anna Marklund
- Harald Holte
- Alexander Fosså
- Knut B. Smeland
- Tarec Christoffer El-Galaly
- Sandra Eloranta
-
T066: Treatment and sex-specific exposure-based risk-stratification for care of survivors of childhood Hodgkin Lymphoma: A report from the Childhood Cancer Survivor Study.
Abstract Talk in Living beyond Lymphoma (Sunday 10:30–12:00)
View full abstract at Hemasphere…
- Michaela Dinan
- Kayla Stratton
- Wendy Leisenring
- Yutaka Yasui
- Eric Chow
- Emily Tonorezos
- Chaya Moskowitz
- Jennifer Yeh
- David Noyd
- Gregory Armstrong
- Kevin Oeffinger
-
P067: A pilot of lung cancer screening for survivors of Hodgkin lymphoma
View full abstract at Hemasphere…
- Rachel Broadbent
- Philip Crosbie
- John Radford
- Christopher J. Armitage
- Ben Taylor
- Joseph Mercer
- Sean Tenant
- Kim Linton
-
P068: A Retrospective Analysis of Fertility in Female Patients with Advanced Stages of Hodgkin Lymphoma Treated with BEACOPP Escalated Chemotherapy (25 Year Experience of a Single Centre)
View full abstract at Hemasphere…
- Jana Marková
- Heidi Mociková
- Lubica Gaherová
- Katerina Klásková
- Maria Maco
- Katerina Dedeckova
- Tomas Kozak
-
P069: Characterisation of influencing parameters on oocyte quality preservation in a cohort of Hodgkin lymphoma patients
View full abstract at Hemasphere…
- Chloé Chuzel
- Virginie Simon
- Hélène Béhal
- Franck Morschhauser
- Christine Decanter
- Morgane Nudel
-
P070: Design of the INSIGHT study, evaluation of long-term follow-up care for lymphoma survivors in the Netherlands: does survivorship care at the BETER clinics reduce morbidity and mortality from late effects of lymphoma treatment and associated costs?
View full abstract at Hemasphere…
- Annelies Nijdam
- Eline M.J. Lammers
- Berthe M. P. Aleman
- Josée M. Zijlstra
- Flora E. van Leeuwen
- on behalf of the BETER consortium
-
P071: First results of cardiovascular screening in a survivorship care program for Hodgkin lymphoma survivors in the Netherlands
View full abstract at Hemasphere…
- Eline M.J. Lammers
- Annelies Nijdam
- Josée M. Zijlstra
- Cécile P.M. Janus
- Roel J. de Weijer
- Flora E. van Leeuwen
- Berthe M. P. Aleman
- on behalf of the BETER consortium
-
P072: Impact of Ageing on the Survivorship Experiences of Patients with Hodgkin Lymphoma
View full abstract at Hemasphere…
- Cherie Bates
- Funmi Bamigbola
- Lorna Warwick
-
P073: Increased risk of colorectal cancer following treatment for Hodgkin lymphoma
View full abstract at Hemasphere…
- Yvonne M.G. Geurts
- Rebecca Shakir
- Georgios Ntentas
- Sander Roberti
- Marianne Aznar
- Katinka John
- Johanna Ramroth
- Cécile P.M. Janus
- Augustinus Krol
- Judith Roesink
- Richard W.M. van der Maazen
- Josée M. Zijlstra
- Sarah Darby
- Berthe M. P. Aleman
- Flora E. van Leeuwen
- David Cutter
- Michael Schaapveld
-
P074: Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients – A Nationwide Danish Cohort Study
View full abstract at Hemasphere…
- Sára Rossetti
- Sidsel Jacobsen Juul
- Frank Eriksson
- Peder Emil Warming
- Charlotte Glinge
- Tarec Christoffer El-Galaly
- Jacob Haaber Christensen
- Peter Kamper
- Peter de Nully Brown
- Maja Vestmø Maraldo
- Jacob Tfelt-Hansen
- Martin Hutchings
-
P075: My Hodgkin, My Health: Feasibility of a mobile application to collect long term follow up data about Hodgkin patients.
View full abstract at Hemasphere…
- Gajan Kailainathan
- Janlyn Falconer
- Amy Baker
- Nicole Wong Doo
- Judith Trotman
-
P076: Pneumococcal infection in splenectomised Hodgkin lymphoma patients: Do they pose a problem today and what is the best long-term strategy?
View full abstract at Hemasphere…
- Magnus Björkholm
- Caroline E. Weibull
- Paul Dickman
-
P077: Predicting radiotherapy dose to the heart and the risk of radiation-related cardiac toxicity for Hodgkin lymphoma patients, using pre-chemotherapy PET-CT scans
View full abstract at Hemasphere…
- Rebecca Shakir
- Victoria Butterworth
- Georgios Ntentas
- Johanna Ramroth
- David Cutter
-
P078: Predicting the Health-Related Quality of Life of Hodgkin Lymphoma Survivors: Identification of Risk Factors
View full abstract at Hemasphere…
- Nele Stadtbaeumer
- Axel Mayer
- Peter Borchmann
-
P079: PROCTCAE as a patient-reported outcome measurement (PROM) questionaire in patients with Hodgkin Lymphoma captures different adverse events profile than those reported by physicians
View full abstract at Hemasphere…
- Sergio Ramos-Cillan
- Eva Castillo
- Miriam Riesco
- Antonio Herroro
- Adriana Pascual
- Alberto Lopez-Garcia
- Maria Angeles Perez
- Daniel Morillo
- ALham Askari
- Elena Prieto
- Pilar LLamas
- Javier Becares
- Carla Barriocanal
- Marta Del Olmo
- Jorge Short
- Javier Arcos
- Raul Córdoba
-
P080: The BETER-REFLECT Biobank: a REsource For studies on Late Effects of Cancer Treatment
View full abstract at Hemasphere…
- Adinda Mieras
- Annelies Nijdam
- Berthe M. P. Aleman
- Laurien Daniels
- Eva de Jongh
- Cécile P.M. Janus
- Stijn Krol
- Bastiaan D.P. Ta
- Francisca Ong
- Dick Johan van Spronsen
- Ward Posthuma
- Wouter J. Plattel
- Rimke Oostvogels
- Karijn Verschueren
- Josée M. Zijlstra
- Flora E. van Leeuwen
-
P081: Treatment-related circulatory diseases and mortality in Hodgkin lymphoma patients using multi-state modelling and relative survival
View full abstract at Hemasphere…
- Joachim Baech
- Lasse Hjort Jakobsen
- Tarec Christoffer El-Galaly
- Daniel Molin
- Ingrid Glimelius
- Joshua P. Entrop
- Michael J. Crowther
- Karin E. Smedby
- Sandra Eloranta
- Caroline E. Weibull
Older & Frail Patients
-
T082: AVD - a possible golden standard in the first-line treatment of older classical Hodgkin lymphoma patients.
Abstract Talk in Older and Frail Patients (Sunday 14:00–15:30)
View full abstract at Hemasphere…
- Ninja Övergaard
- Kjersti Lia
- Peter Asdahl
- Per Wikman
- Ingrid Glimelius
- Ingemar Lagerlöf
- Ann-Sofie Johansson
- Lotta Hansson
- Gunilla Enblad
- Johan Linderoth
- Christina Goldkuhl
- Alexander Fosså
- Peter Kamper
- Daniel Molin
-
T083: The Effect of Heart Failure on Management and Outcomes of Older Patients with Hodgkin Lymphoma
Abstract Talk in Older and Frail Patients (Sunday 14:00–15:30)
View full abstract at Hemasphere…
- Jenica Upshaw
- Jason Nelson
- Angie Mae Rodday
- Anita Kumar
- Andreas Klein
- Marvin Konstam
- John Wong
- Iris Jaffe
- Bonnie Ky
- Jonathan W. Friedberg
- Matthew Mauer
- David Kent
- Susan K. Parsons
-
T084: Treatment patterns and outcomes for Hodgkin's Lymphoma (HL) patients (pts) aged 60 and older: a report from the Brazilian Prospective Hodgkin’s lymphoma Registry
Abstract Talk in Older and Frail Patients (Sunday 14:00–15:30)
View full abstract at Hemasphere…
- Lilian Goveia
- Nelson Castro
- Carmino de Souza
- Carolina Colaço Villarim
- Fabiola Traina
- Carlos Sergio Chiattone
- Monica Praxedes
- Cristiana Solza
- Leila Perobelli
- Otavio Baiocchi
- Rafael Gaiolla
- Carla Boquimpani
- Valeria Buccheri
- Caroline Bonamin Sola
- Roberta Oliveira de Paula e Silva
- Ana Carolina Ribas
- Giovana Steffenello
- Katia Pagnano
- Andrea Soares
- Samuel Souza Medina
- Talita Silveira
- Karin Zattar Cecyn
- Leonardo Carvalho Palma
- Mariana de Oliveira Marques
- Nelson Spector
- Irene Biasoli
-
P085: Epidemiology and results of the first line therapy of HIV-related Hodgkin Lymphoma: Russian retrospective multicenter study
View full abstract at Hemasphere…
- Andrey Chekalov
- Marina Popova
- Ivan Tsygankov
- Yuliya Rogacheva
- Nikita Volkov
- Anastasia Beynarovich
- Kirill Lepik
- Marina Demchenkova
- Marina Grigorieva
- Tatiana Schneider
- Yuliya Kopeikina
- Natalia Medvedeva
- Ilya Zyuzgin
- Elena Pavlyuchenko
- Alexander Levanov
- Alexander Myasnikov
- Natalia Mikhailova
- Vadim Baykov
- Alexander Kulagin
Immunotherapy
-
T057: Circulating tumor DNA in classical Hodgkin lymphoma patients treated with pembrolizumab and chemotherapy: dynamic response assessment and correlation with baseline total metabolic tumor volume
Abstract Talk in Immunotherapy (Sunday 18:00–19:30)
View full abstract at Hemasphere…
- Ryan C. Lynch
- Stefan Alig
- Chaitra S. Ujjani
- Christina Poh
- Edus H. Warren
- Stephen D. Smith
- Mazyar Shadman
- Andrei Shustov
- Brian Till
- Vikram M. Raghunathan
- Yolanda Tseng
- Hilary Coye
- Megan Shelby
- Susan Ottemiller
- Sarith Keo
- Kaitlin Verni
- Hongyan Du
- Jackie Vandermeer
- Ashley Gaston
- Heather Rasmussen
- Avanti Gulhane
- Delphine L. Chen
- Paul Martin
- Edmond Marzbani
- Jenna Voutsinas
- Ash A. Alizadeh
- Ajay K. Gopal
-
P061: Safety and Dose-Expansion Study of Combination Favezelimab (anti–LAG-3) Plus Pembrolizumab in Anti–PD-1–Naive Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
Abstract Talk in Immunotherapy (Sunday 18:00–19:30)
View full abstract at Hemasphere…
- Peter Borchmann
- Nathalie A. Johnson
- David Lavie
- Gareth Gregory
- Alex F. Herrera
- Leonard Minuk
- Vladan Vucinic
- Philippe Armand
- Abraham Avigdor
- Robin Gasiorowski
- Yair Herishanu
- Colm Keane
- John Kuruvilla
- John Palcza
- Pallavi Pillai
- Akash Nahar
- John Timmerman
-
P059: Multi-effector cell targeting with half-life extended bispecific scFv in Hodgkin lymphoma
View full abstract at Hemasphere…
- Zhiyuan Shi
- Verena Kern
- Max Freihammer
- Jennifer Schitz
- Sven Borchmann
-
P060: Prognosis of patients with relapsed and refractory classic Hodgkin lymphoma after nivolumab discontinuation and efficacy of nivolumab retreatment
View full abstract at Hemasphere…
- Liudmila Fedorova
- Kirill Lepik
- Natalia Mikhailova
- Elena Kondakova
- Yaroslava Komarova
- Polina Kotselyabina
- Evgenia Borzenkova
- Vadim Baykov
- Ivan Moiseev
- Alexander Kulagin
-
P062: The efficacy and safety of nivolumab 40 mg therapy versus 3 mg/kg in patients with relapsed and refractory classic Hodgkin lymphoma
View full abstract at Hemasphere…
- Liudmila Fedorova
- Kirill Lepik
- Natalia Mikhailova
- Elena Kondakova
- Yaroslava Komarova
- Polina Kotselyabina
- Evgenia Borzenkova
- Vadim Baykov
- Ivan Moiseev
- Alexander Kulagin
-
P063: Trial in Progress: Individualized Immunotherapy in Early-Stage Unfavorable Hodgkin Lymphoma - The Investigator-Initiated Phase II GHSG INDIE Trial
View full abstract at Hemasphere…
- Paul J. Bröckelmann
- Helen Kaul
- Michael Fuchs
- Carsten Kobe
- Christian Baues
- Peter Borchmann
- Andreas Engert
-
T058: Safety and Dose-Expansion Study of Combination Favezelimab (anti–LAG-3) Plus Pembrolizumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma Refractory to Anti–PD-1 Treatment
View full abstract at Hemasphere…
- John Timmerman
- David Lavie
- Nathalie A. Johnson
- Abraham Avigdor
- Peter Borchmann
- Charalambos Andreadis
- Ali Bazargan
- Gareth Gregory
- Colm Keane
- Inna Tzoran
- Vladan Vucinic
- Pier Luigi Zinzani
- Hong Zhang
- Pallavi Pillai
- Akash Nahar
- Alex F. Herrera
Advanced Stages
-
T001: FDG-PET and serum TARC levels after one cycle of BV-AVD in advanced stage Hodgkin lymphoma patients: results from the very early PET-response adapted EORTC-COBRA trial
Abstract Talk in Advanced Stages (Monday 07:30–09:00)
View full abstract at Hemasphere…
- Arjan Diepstra
- Lydia Visser
- Catherine Fortpied
- Walter Noordzij
- Annika Loft
- Anne Arens
- Anna Sureda-Balari
- Susana Carvalho
- Andrej Vranovský
- Ward Sents
- Emanuel Buhrer
- Wouter J. Plattel
- Martin Hutchings
-
T002: Treatment related morbidity in patients with classical Hodgkin Lymphoma: results of the ongoing, randomized phase III HD21 Trial by The German Hodgkin Study Group
Abstract Talk in Advanced Stages (Monday 07:30–09:00)
View full abstract at Hemasphere…
- Peter Borchmann
- Alden Moccia
- Richard Greil
- Mark Herzberg
- Alexander Fosså
- Andreas Hüttmann
- Felix Keil
- Judith Dierlamm
- Valdete Schaub
- Mathias Hänel
- Urban Novak
- Julia Meissner
- Johannes Hellmuth
- Stephan Mathas
- Josée M. Zijlstra
- Andreas Viardot
- Bernd Hertenstein
- Sonja Martin
- Pratush Giri
- Stefanie Kreissl
- Michael Fuchs
- Gundolf Schneider
- Andreas Rosenwald
- Wolfram Klapper
- Hans Theodor Eich
- Christian Baues
- Michael Hallek
- Carsten Kobe
- Volker Diehl
- Andreas Engert
-
P003: A retrospective study to evaluate the reliability of staging and risk stratification of adolescent and adult patients with Hodgkin’s lymphoma registered in the lymphoma clinic at Tata Memorial Centre.
View full abstract at Hemasphere…
- Hasmukh Jain
- Ajay Singh
- Manju Sengar
- Thomas Eipe
- Hiral Mehta
- Bhausaheb Bagal
- Jayashree Thorat
- Lingaraj Nayak
- Neha Sharma
-
P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim-PET (PET-2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patient data of three multicenter trials
View full abstract at Hemasphere…
- Simonetta Viviani
- Chiara Pavoni
- Sally F. Barrington
- Luca Guerra
- Heiko Schöder
- Peter Johnson
- Amy A. Kirkwood
- Deborah M. Stephens
- Jonathan W. Friedberg
- Stephane Chauvie
- Michael V. Knopp
- Massimo Federico
- Gunilla Enblad
- Paolo Corradini
- Andrea Gallamini
- Alessandro Rambaldi
- Corrado Tarella
-
P005: Age, histotype and stage IV are associated with a shorter survival in patients with Hodgkin lymphoma, even the PET-adapted era. A single center retrospective study.
View full abstract at Hemasphere…
- Andrea Visentin
- Alessandro Cellini
- Chiara Adele Cavarretta
- Leila Romano Gargarella
- Francesco Angotzi
- Valeria Ruocco
- Simone Zoletto
- Stefano Pravato
- Marco Pizzi
- Federica Vianello
- Filippo Crimì
- Stefania Vio
- Michele Gregianin
- Livio Trentin
-
P006: Clinical outcome of classical Hodgkin Lymphoma patients receiving systemic anti-lymphoma treatment during SARS-COV-2 positivity: Results from the chemo-covid study on behalf of fondazione italiana linfomi
View full abstract at Hemasphere…
- Chiara Rusconi
- Benedetta Puccini
- Carlo Visco
- Francesca Ricci
- Alessandro Re
- Vittorio R. Zilioli
- Caterina Zerbi
- Stefan Hohaus
- Federico Mazzon
- Manuel Ciceri
- Anna Guidetti
- Vincenzo Marasco
- Luigi Rigacci
-
P007: Comparative efficacy of the R-BEACOPP-14 and R-CHOP regimens in the treatment of patients with advanced stages of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with THRLBCL-like histopathological growth patterns in the tumor biopsy
View full abstract at Hemasphere…
- Elena Dorokhina
- T.N. Moiseeva
- A.M. Kovrigina
- Irirna Shupletsova
- L.S. Al-Radi
- Yu. A. Chabaeva
- Ya.K. Mangasarova
-
P008: Impact of bone marrow involvement on early PET response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphoma
View full abstract at Hemasphere…
- Conrad-Amadeus Voltin
- Stefanie Kreissl
- Helen Kaul
- Ina Bühnen
- Jasmin Mettler
- Thomas Pabst
- Dennis A. Eichenauer
- Michael Fuchs
- Volker Diehl
- Markus Dietlein
- Andreas Engert
- Peter Borchmann
- Carsten Kobe
-
P009: Improved Overall Survival with First-Line Brentuximab Vedotin plus Chemotherapy in Patients with Advanced Stage III/IV Classical Hodgkin Lymphoma: An Updated Analysis of ECHELON-1
View full abstract at Hemasphere…
- Martin Hutchings
- Stephen M. Ansell
- Joseph M. Connors
- Won Seog Kim
- Andrea Gallamini
- Radhakrishnan Ramchandren
- Jonathan W. Friedberg
- Ranjana Advani
- Andrew M. Evens
- Piotr Smolewski
- Kerry J. Savage
- Nancy L. Bartlett
- Hyeon-Seok Eom
- Jeremy S. Abramson
- Cassie Dong
- Frank Campana
- Keenan Fenton
- Markus Puhlmann
- David J. Straus
- John Radford
-
P010: Inferior Outcomes for Young Adults Treated on Advanced Stage Clinical Trials: Report from the HoLISTIC Consortium
View full abstract at Hemasphere…
- Susan K. Parsons
- Angie Mae Rodday
- Jonathan W. Friedberg
- Andrea Gallamini
- Eliza Hawkes
- David Hodgson
- Peter Johnson
- Brian Link
- Matthew Maurer
- Jason Nelson
- Kerry J. Savage
- Jenica Upshaw
- Pier Luigi Zinzani
- Andrew M. Evens
-
P011: IPS-7 or IPS-3 to identify very-high risk patients in advanced Classical Hodgkin ́s Lymphoma: Which score to choose
View full abstract at Hemasphere…
- Cátia Almeida
- Rita Costa e Sousa
- Adriana Roque
- Maria Carolina Afonso
- Dulcelena Neves
- Raquel Guilherme
- Lenka Ruzickova
- José Pedro Carda
- Catarina Geraldes
- Marília Gomes
-
P012: Nodular Lymphocyte-predominant Hodgkin Lymphoma a rare disease with good prognosis: a retrospective multicenter experience
View full abstract at Hemasphere…
- Francesca Pierdomenico
- Raquel Marques
- Dulcelena Neves
- João Gaião Santos
- Christopher Saunders
- Rita Pinho Peixeiro
- Marta Henriques
- Ana Tome
- Daniela Alves
- Margarida Badior
- Tathiane Lopes
- Sonia Leocadio
- Marília Gomes
- Alexandra Monteiro
- Rita Coutinho
- Ana Luisa Pinto
- Anabela Neves
- João Paulo Fernandes
- Maria Gomes da Silva
-
P013: Outcomes of first-line treatment (FL) of classical Hodgkin lymphoma (cHL) in Argentina: a real life multicenter retrospective study
View full abstract at Hemasphere…
- Korin Laura
- Victoria Otero
- Carolina Mahuad
- Enriqueta Martinez
- Fernando Warley
- Hernan García Rivello
- Nancy Cristaldo
- Dana Kohan
- Gonzalo Garate
- Maria de los Angeles Vicente Reparaz
- Maria Florencia Aizpurua
- Erica Rojas Bilbao
- Susana Cerana
- María Eugenia Funes
- Iliana Plaza
- Cecilia Foncuberta
- Anahi Vijnovich Baron
- Santiago Cranco
- Adriana Vitriu
- Mariela Gomez
- Justina Lavalle
- Claudia Casali
- Manuela Clavijo
- Luciana Melillo
- Maria Cecilia Cabral Lorenzo
- Augusto Miroli
- Laura Fishman
- Maximi
-
P014: Prognostic significance of nutritional indexes (CONUT and PNI) in classical Hodgkin lymphoma patients
View full abstract at Hemasphere…
- Rita Costa e Sousa
- Cátia Almeida
- Adriana Roque
- Maria Carolina Afonso
- Dulcelena Neves
- Raquel Guilherme
- Lenka Ruzickova
- José Pedro Carda
- Catarina Geraldes
- Marília Gomes
-
P015: Real World Escalated BEACOPDac Delivers Similar Outcomes to Escalated BEACOPP While Potentially Reducing Haematopoietic and Reproductive Toxicity
View full abstract at Hemasphere…
- Anna Santarsieri
- Katherine Sturgess
- Pauline Brice
- Tobias F. Menne
- Wendy Osborne
- Thomas Creasey
- Kirit M. Ardeshna
- Sarah Behan
- Kaljit Bhuller
- Stephen Booth
- Nikesh Chavda
- Graham P. Collins
- Dominic Culligan
- Kate Cwynarski
- Andrew Davies
- David Dutton
- Michelle Furtado
- Eve Gallop-Evans
- Andrew Hodson
- David Hopkins
- Hannah Hsu
- Sunil Iyengar
- Stephen G. Jones
- Kim Linton
- Oliver Lomas
- Nicolas Martinez-Calle
- Abhinav Mathur
- Pamela McKay
- Sateesh K. Nagumantry
- Deidre O'Mahony
- Beth Phillips
- Neil
-
P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP)
View full abstract at Hemasphere…
- Ida Hude Dragičević
- Sandra Bašić-Kinda
- Dino Dujmović
- Ivo Radman
- Barbara Dreta
- Sandra Dotlić
- Lea Galunić-Bilić
- Margareta Dobrenić
- Marko Kralik
- Pavle Rončević
- Igor Aurer
-
P017: The role of baseline bulk and dissemination measures as predictors of progression in advanced Hodgkin lymphoma.
View full abstract at Hemasphere…
- Michal Taszner
- Grzegorz Romanowicz
- Wanda Knopińska-Posłuszny
- Janusz Hałka
- Edyta Subocz
- Bogdan Małkowski
- Jan Maciej Zaucha
-
P018: Treatment outcomes in classical Hodgkin lymphoma (HL): 5-year update report from the Brazilian Prospective Registry
View full abstract at Hemasphere…
- Irene Biasoli
- Nelson Castro
- Carolina Colaço Villarim
- Fabiola Traina
- Carlos Sergio Chiattone
- Monica Praxedes
- Cristiana Solza
- Leila Perobelli
- Otavio Baiocchi
- Rafael Gaiolla
- Carla Boquimpani
- Valeria Buccheri
- Caroline Bonamin Sola
- Roberta Oliveira de Paula e Silva
- Ana Carolina Ribas
- Giovana Steffenello
- Katia Pagnano
- Andrea Soares
- Samuel Souza Medina
- Talita Silveira
- Karin Zattar Cecyn
- Lilian Goveia
- Leonardo Carvalho Palma
- Mariana de Oliveira Marques
- Carmino de Souza
- Nelson Spector
-
P019: Unfavorable prognostic value of the predominance of THRLBCL-like histopathological growth patterns in nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL)
View full abstract at Hemasphere…
- Elena Dorokhina
- T.N. Moiseeva
- A.M. Kovrigina
- Irirna Shupletsova
- L.S. Al-Radi
- Yu. A. Chabaeva
- Ya.K. Mangasarova
Genomics, Biology & Microenvironment
-
T026: Characterization of cancer-associated fibroblasts in classical Hodgkin lymphoma
Abstract Talk in Genomics, Biology and Microenvironment (Monday 10:30–12:00)
View full abstract at Hemasphere…
- Kristiina Karihtala
- Suvi-Katri Leivonen
- Marja-Liisa Karjalainen-Lindsberg
- Arne Östman
- Teijo Pellinen
- Sirpa Leppä
-
T027: High serum levels of Thymus and Activation Related Chemokine (TARC) precede Hodgkin lymphoma diagnosis by several years
Abstract Talk in Genomics, Biology and Microenvironment (Monday 10:30–12:00)
View full abstract at Hemasphere…
- Arjan Diepstra
- Ilja M. Nolte
- Anke van den Berg
- Lynn I. Levin
- Otoniel Martínez-Maza
-
T028: Single-cell RNA sequencing reveals the interplay between circulating CD4 T cells, B cells and cancer-associated monocytes in classic Hodgkin lymphoma treated with PD-1 blockade
Abstract Talk in Genomics, Biology and Microenvironment (Monday 10:30–12:00)
View full abstract at Hemasphere…
- Julia Paczkowska
- Ming Tang
- Kyle T. Wright
- Li Song
- Vignesh Shanmugam
- Kelsey Luu
- Emma L. Welsh
- Fathima Zumla Cader
- Elisa Mandato
- Jing Ouyang
- Gali Bai
- Lee Lawton
- Scott Rodig
- X Shirley Liu
- Margaret A. Shipp
-
P029: Are Reed-Sternberg cells stuck in mitosis by short nucleoplasmic bridges as a consequence of centromeric instability?
View full abstract at Hemasphere…
- Radhia M'kacher
- Steffen Junker
- Bruno Colicchio
- Wala Najar
- Justyna Mika
- Alain Dieterlen
- Joanna Polanska
- Philippe Voisin
- Eric Jeandidier
- Patrice Carde
-
P030: Baseline IgM amount can identify patients with adverse outcome despite a PET-2 adapted treatment in classical Hodgkin Lymphoma: results from a real-life single-center study i
View full abstract at Hemasphere…
- Alessandra Romano
- Claudio Cerchione
- Gabriella Santuccio
- Marialudovica Le Moli
- Annalisa Chiarenza
- Amalia Figuera
- Giovanna Motta
- L. Caruso
- Sofia Lanza
- A. Petronaci
- S. Poidomani
- Massimo Ippolito
- Francesco Di Raimondo
-
P031: CD4+ T cells in close proximity to Hodgkin-Reed Sternberg cells are antigen experienced, polyclonal and display an exhausted phenotype
View full abstract at Hemasphere…
- Johanna Veldman
- Jessica Rodrigues Plaça
- Lauren Chong
- Martijn Terpstra
- Mirjam Mastik
- Léon C. van Kempen
- Tomohiro Aoki
- Christian Steidl
- Anke van den Berg
- Lydia Visser
- Arjan Diepstra
-
P032: Circulating immune biomarkers in classical Hodgkin lymphoma in relation to tumor burden and response to treatment.
View full abstract at Hemasphere…
- Tom A. Mulder
- Maria L. Andersson
- Lucia Peña-Pérez
- Kia Heimersson
- Ioanna Xagoraris
- Björn E. Wahlin
- Robert Månsson
- Lotta Hansson
- Georgios Z. Rassidakis
- Marzia Palma
-
P033: Clinical significance of the severity of THRLBCL-like areas in nodular lymphocyte predominant Hodgkin lymphoma
View full abstract at Hemasphere…
- Irirna Shupletsova
- Alla Kovrigina
- Elena Dorokhina
- Tatyana Moiseeva
-
P034: Correlation between MTV, TLG and Serum TARC Concentration in Classical Hodgkin Lymphoma during First-Line Treatment
View full abstract at Hemasphere…
- Ilaria Romano
- Benedetta Puccini
- Elisabetta Abenavoli
- Leonardo Signori
- Marianna Palazzo
- Manuel Ciceri
- Benedetta Sordi
- Valentina Berti
- Michela Zizza
- Fabiana Pancani
- Luca Nassi
- Alessandro Maria Vannucchi
-
P035: CRISPR/Cas9-mediated knockout reveals an important role of CD30 in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma
View full abstract at Hemasphere…
- Annika L. Kilian
- Anna Lollies
- Marc A. Weniger
- Ralf Küppers
-
P036: Detection of recurrent somatic variants in cell-free DNA as a tool for disease monitoring in Hodgkin lymphoma
View full abstract at Hemasphere…
- Jan Grohmann
- Alexandra Kredatusova
- Jana Navratilova
- Veronika Hanackova
- Helena Urbankova
- Vit Prochazka
- Tomas Papajik
-
P037: High breadth whole exome sequencing of circulating tumor DNA identifies novel recurrent genetic alterations in Hodgkin lymphoma
View full abstract at Hemasphere…
- Laman Mammadova
- Jan-Michel Heger
- Julia Mattlener
- Sophia Sobesky
- Melita Cirillo
- Paul J. Bröckelmann
- Janine Altmüller
- Elisabeth Kirst
- Stefanie Kreissl
- Mia Lohmann
- Peter Nürnberg
- Andreas Engert
- Peter Borchmann
- Bastian von Tresckow
- Sven Borchmann
-
P038: HLA expression patterns of Hodgkin-Reed-Sternberg cells shape a spatially arranged tumor microenvironment in classical Hodgkin lymphoma
View full abstract at Hemasphere…
- Berit Müller-Meinhard
- Sarah Reinke
- Nicole Seifert
- Andreas Engert
- Paul J. Bröckelmann
- Michael Altenbuchinger
- Wolfram Klapper
-
P039: HLA expression status and prognostic impact of B-cell content in patients with early-stage unfavorable Hodgkin lymphoma
View full abstract at Hemasphere…
- Johanna Grund
- Sarah Reinke
- Annette Plütschow
- Bastian von Tresckow
- Peter Borchmann
- Andreas Engert
- Paul J. Bröckelmann
- Wolfram Klapper
-
P040: LINE-1 reverse transcriptase activity in Hodgkin lymphoma cells
View full abstract at Hemasphere…
- Annika Wadel
- Leonie Jaster
- Martin S. Staege
-
P041: Low percentage of T lymphocytes in Hodgkin's Lymphoma lymph nodes, measured by flow cytometry, is associated with inferior progression free survival regardless of negative interim pet scan status
View full abstract at Hemasphere…
- Laura Korin
- Santiago Cranco
- Lucia Fuente
- Adriana Vitriu
- Paola Ochoa
- Evelina Babuin
- Olivia Gelo
- Luis Ayala
- Andrea Novoa
- Paula Tempra
- Maria Belen Venegas
- Anahi Vijnovich Baron
- Norma Tartas
- Rosario Custidiano
- Cecilia Foncuberta
- Julio Sanchez Avalos
-
P042: Metabolic regulation of adaptive response to arginine deprivation in Hodgkin Lymphoma
View full abstract at Hemasphere…
- Alessandra Romano
- Grazia Scandura
- Gabriella Santuccio
- Fabrizio Puglisi
- Daniela Cambria
- Angela Maria Amorini
- Enrico La Spina
- Nunziatina Laura Parrinello
- Cesarina Giallongo
- Daniele Tibullo
- Claudio Cerchione
- Giovanni Martinelli
- Giorgia Simonetti
- Francesco Di Raimondo
-
P043: Molecular pathogenesis of Hodgkin lymphoma
View full abstract at Hemasphere…
- Lilian Beeck
- Markus Schneider
- Navid Farsijani
- Bettina Budeus
- Julia Bein
- Hendrik Schaefer
- Sylvia Hartmann
- Martin-Leo Hansmann
- Ralf Küppers
-
P044: PIM kinases support protumoral and immunosuppressive phenotype and functions of macrophages in classical Hodgkin Lymphoma
View full abstract at Hemasphere…
- Maciej Szydłowski
- Filip Garbicz
- Ewa Kurtz
- Michał Pawlak
- Patryk Górniak
- Anna Szumera-Ciećkiewicz
- Kamil Sokół
- Monika Kawecka
- Daria Owczarek
- Beata Puton
- Monika Prochorec-Sobieszek
- Daniela Bellarosa
- Michał Kurlapski
- Jan Maciej Zaucha
- Przemysław Juszczyński
-
P045: Plasma proteome profiling of cardiotoxicity in patients with Hodgkin lymphoma
View full abstract at Hemasphere…
- Johan Mattsson Ulfstedt
- Eva Freyhult
- Christina Christersson
- Charlott Mörth
- Masood Kamali-Moghaddam
- Anna Eriksson
- Gunilla Enblad
- Daniel Molin
-
P046: Preclinical evaluation of novel repurposed drug combinations in Hodgkin lymphoma
View full abstract at Hemasphere…
- Mia Lohmann
- Iris Buchberger
- Anna Beielstein
- Başak Kaçar
- Julia Mattlener
- Marieke Nill
- Zhiyuan Shi
- Jan-Michel Heger
- Christian Pallasch
- Roland Ullrich
- Sven Borchmann
-
P047: Predictive role of the Hodgkin lymphoma-associated cytokines: a prospective study of the Czech Hodgkin Study Group
View full abstract at Hemasphere…
- Vit Prochazka
- Heidi Mocikova
- Alice Sykorova
- Jana Markova
- Marie Lukášová
- Lubica Gaherova
- Alexandra Kredatusova
- Eva Kriegova
- Maria Maco
- Tomas Kozak
- David Belada
- Tomas Papajik
-
P048: Predictors of risk of relapse in classic Hodgkin lymphoma by flow cytometry
View full abstract at Hemasphere…
- Jonathan Fromm
- Claire Tang
- Kikkeri N. Naresh
-
P049: Reduced features of T-cell activation before and during anti-PD-1 treatment in classical Hodgkin lymphoma
View full abstract at Hemasphere…
- Nicole Seifert
- Sarah Reinke
- Johanna Grund
- Berit Müller-Meinhard
- Andreas Engert
- Paul J. Bröckelmann
- Wolfram Klapper
- Michael Altenbuchinger
-
P050: Reed-Sternberg cells accelerate glycolytic and mitochondrial metabolism of tumor microenvironment cells
View full abstract at Hemasphere…
- Michał Kurlapski
- Maciej Szydłowski
- Alicja Braczko
- Marika Frańczak
- Maciej Zieliński
- Ryszard Smoleński
- Przemysław Juszczyński
- Jan Maciej Zaucha
-
P051: Serum procalcitonin levels in newly diagnosed classical Hodgkin Lymphoma (cHL): Correlation with other inflammatory biomarkers
View full abstract at Hemasphere…
- Alexia Piperidou
- Eleftherios Zografos
- Theodoros P. Vassilakopoulos
- Maria K. Angelopoulou
- Georgios Hlias
- Vassiliki Pappis
- George Boutsikas
- Maria Dimou
- Kyriaki Petevi
- Alexandros Kanellopoulos
- Marie-Christine Kyrtsonis
- Panayiotis Panayiotidis
-
P052: Targeting CSN5/JAB1 oncogene in classical Hodgkin Lymphoma (cHL)
View full abstract at Hemasphere…
- Ioanna Xagoraris
- Konstantina Stathopoulou
- Stefanie Renken
- Andreas Lundqvist
- Francois Xavier Claret
- Elias Drakos
- Georgios Z. Rassidakis
-
P053: The cGAS-STING anti-tumor immune response pathway as a potential therapeutic target in classical Hodgkin Lymphoma (cHL)
View full abstract at Hemasphere…
- Ioanna Xagoraris
- Konstantina Stathopoulou
- Persa Xyderou
- Marzia Palma
- Elias Drakos
- Theodoros P. Vassilakopoulos
- Georgios Z. Rassidakis
-
P054: The Kinase CK2 is deregulated and targetable in classical Hodgkin Lymphoma
View full abstract at Hemasphere…
- Andrea Visentin
- Edoardo Ruggeri
- Federica Frezzato
- Marco Pizzi
- Alessandro Cellini
- Francesco Angotzi
- Chiara Adele Cavarretta
- Valeria Ruocco
- Stefano Pravato
- Filippo Severin
- Monica Facco
- Sabrina Manni
- Francesci Piazza
- Livio Trentin
-
P055: Validation of the tumor cell-specific rearranged IgG-encoding circulating cell-free DNA for the treatment response monitoring in patients with classic Hodgkin lymphoma
View full abstract at Hemasphere…
- Ilia Buhtoiarov
- Brian Hill
- Ilan Kirsch
- Nancy Richter
- Rabi Hanna
-
P056: Variants of the transcription factor ONECUT2 regulate gene expression in Hodgkin Lymphoma cells
View full abstract at Hemasphere…
- Patricia Lein
- Charles Gwellem Anchang
- Ines Volkmer
- Martin S. Staege
-
P115: Distinct signaling pathways and checkpoint molecule expression across histological subtypes of nodular lymphocyte-predominant Hodgkin lymphoma
View full abstract at Hemasphere…
- Ilja Kalashnikov
- Rachel Kositsky
- Marja-Liisa Karjalainen-Lindsberg
- Johannes Dunkel
- Annika Pasanen
- Cassandra Love
- Clay Parker
- Sarah Ondrejka
- Eric Hsi
- Ridas Juskevicius
- Andrew Evans
- Andrew G. Evans
- Magdalena Czader
- Lin Wang
- Mina Xu
- Nathan Paulson
- Mette Ølgod Pedersen
- Anne Ortved Gang
- Jean Koff
- Chad McCall
- Yaso Natkunam
- Abner Louissaint
- Ong Shin Yeu
- Raju Pillai
- Jennifer Chapman
- Catalina Amador
- Amy Chadburn
- Rashmi Goswami
- Amir Behdad
- Payal Sojitra
- Eric Tse
- Naresh Kikkeri
- Kikkeri
Relapsed/Refractory
-
T098: Brentuximab Vedotin plus ESHAP (BRESHAP) versus ESHAP in Patients with Relapsed or Refractory Classical Hodgkin’s Lymphoma. Interim Results of the BRESELIBET Prospective Clinical Trial.
Abstract Talk in Relapsed / Refractory HL (Monday 14:00–15:30)
View full abstract at Hemasphere…
- Anna Sureda-Balari
- M. José Terol
- Eva Domingo-Domènech
- Ana Pilar González Rodriguez
- Francisca Hernández Mohedo
- Javier Núñez Céspedes
- Fátima de la Cruz Vicente
- Carmen Martínez Muñoz
- M. Elena Amutio Díaz
- Raul Córdoba
- Antonia Rodríguez Izquierdo
- Samuel Romero Domínguez
- Javier Briones Meijide
- Richard Greil
- Miriam Moreno Velázquez
- Araceli Rubio
- Mariana Bastos Oteiro
- Pilar Gómez
- Irit Avivi
- María Casanova
- Raquel Del Campo García
- Victor Noriega
- José Javier Sánchez Blanco
-
T099: High efficacy and durability of second-line therapy with pembrolizumab, gemcitabine, vinorelbine, and liposomal doxorubicin in the phase II study for relapsed and refractory Hodgkin lymphoma
Abstract Talk in Relapsed / Refractory HL (Monday 14:00–15:30)
View full abstract at Hemasphere…
- Alison J. Moskowitz
- Gunjan Shah
- Heiko Schöder
- Nivetha Ganesan
- Helen Hancock
- Theresa Davey
- Leslie Perez
- Samia Sohail
- Alayna Santarosa
- Charisse Capadona
- Brittney Munayirji
- Anita Kumar
- Oscar Lahoud
- Connie Batlevi
- Paul Hamlin
- David J. Straus
- Colette Owens
- Philip Caron
- Andrew Intlekofer
- Audrey Hamilton
- Steven Horwitz
- Lorenzo Falchi
- William Johnson
- Lia Palomba
- Ariela Noy
- Matthew Matasar
- Georgios Pongas
- Gilles Salles
- Santosha Vardhana
- Beatriz Wills Sanin
- Joachim Yahalom
- Ahmet Dogan
-
T100: Long term Follow-up of a Phase I Study Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma: A trial of the ECOG-ACRIN Research Group (E4412: Arms A-I)
Abstract Talk in Relapsed / Refractory HL (Monday 14:00–15:30)
View full abstract at Hemasphere…
- Catherine Diefenbach
- Opeyemi Jegede
- Richard Ambinder
- Jonathon Cohen
- Michael Robertson
- Kevin David
- Ranjana Advani
- Timothy Fenske
- Stefan Barta
- Neil Palmisiano
- Jakub Svoboda
- David Morgan
- Reem Karmali
- Brad Kahl
- Stephen M. Ansell
-
P101: Combination of immune checkpoint inhibitors with BeGEV in the treatment of patients with relapsed and refractory classical Hodgkin's lymphoma.
View full abstract at Hemasphere…
- Ya.K. Mangasarova
- T.N. Moiseeva
- L.S. Al-Radi
- O.V. Margolin
- L.G. Gorenkova
- E.S. Nesterova
- M.O. Bagova
- E.A. Fastova
- R.R. Abdurashidova
- Z.T. Sarakaeva
- Elena Dorokhina
- S.K. Kravchenko
- A.U. Magomedova
- E.E. Zvonkov
-
P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin Lymphoma
View full abstract at Hemasphere…
- Harsh Shah
- Victoria Vardell
- Erin Zacholski
- Amanda Fegley
- Kalub Fedak
- Suchitra Sundaram
- Sridevi Rajeeve
- Gaurav Goyal
- Haris Hatic
- Pallawi Torka
- Sheeba Ba Aqeel
- Azra Borogovac
- Kira MacDougall
- Shalin Kothari
- Anna Kress
- Dipenkumar Modi
- Elizabeth Travers
- Nitin Chilakamarri
- Elizabeth Brem
- Deborah M. Stephens
- Boyu Hu
- Lindsey Fitzgerlad
- Charlotte Wagner
- Daniel Ermann
-
P103: Comparison of PET-derived parameters in program cell death-1 inhibitor and CD30 antibody drug conjugate-based therapies in patients with advanced stage cHL: A single center experience.
View full abstract at Hemasphere…
- Serageldin Kamel
- Lucia Martiniova
- Eslam Aboismail
- Joo Schmidt
- Sairah Ahmed
- Ranjit Nair
- Raphael E. Steiner
- Michael L. Wang
- Sarita Soebianto
- Gregory Ravizzini
- Tinsu Pan
- Hun Ju Lee
-
P104: Consolidation Therapy with Brentuximab Vedotin after Autologous Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Czech Republic.
View full abstract at Hemasphere…
- Jozef Michalka
- Jana Marková
- Ľubica Gahérová
- Mária Maco
- Vít Procházka
- Jan Kořen
- Alice Sýkorová
- Pavla Štěpánková
- Kateřina Steinerová
- Lekaa Mohammad
- Juraj Ďuraš
- Barbora Velacková
- Tomáš Doležal
- Kateřina Benešová
- Marie Lukášová
- Andrea Janíková
- Zdeněk Král
- Heidi Móciková
-
P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles
View full abstract at Hemasphere…
- Chiara Rusconi
- Francesca Ricci
- Vittorio R. Zilioli
- Vincenzo Marasco
- Eleonora Calabretta
- Anna Guidetti
- Cristina Muzi
- Federico Mazzon
- Margherita Smania
- Martina Sollini
- Erika Meli
- Marcello Rodari
- Emanuele Ravano
- Roberto Cairoli
- Paolo Corradini
- Armando Santoro
-
P106: Dose intensive brentuximab vedotin for platinum resistant recurrent Hodgkin lymphoma is a feasible treatment option - a single center experience
View full abstract at Hemasphere…
- Axel Erenmalm
- Johan Linderoth
-
P107: Effect of Brentuximab Vedotin Addition to Chemotherapy and Prognostic Factors in Patients with Relapsed/Refractory Hodgkin Lymphoma: a Large Multi-Trial Analysis Based on Individual Patient Data
View full abstract at Hemasphere…
- Julia Driessen
- Fer De Wit
- Alex F. Herrera
- Pier Luigi Zinzani
- Ann S. LaCasce
- Peter D. Cole
- Craig H. Moskowitz
- Ramón García Sanz
- Michael Fuchs
- Horst Müller
- Peter Borchmann
- Armando Santoro
- Heiko Schöder
- Josée M. Zijlstra
- Barbara A. Hutten
- Alison J. Moskowitz
- Marie José Kersten
-
P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma
View full abstract at Hemasphere…
- Eleonora Calabretta
- Martina Di Trani
- Martina Sollini
- Francesca Ricci
- Francesco Corrado
- Vanessa Cristaldi
- Stefanos Bonovas
- Fabrizio Marino
- Rita Mazza
- Lodovico Terzi di Bergamo
- Alessio Bruscaggin
- Maria Cristina Pirosa
- Stefania Bramanti
- Arturo Chiti
- Armando Santoro
- Davide Rossi
- Carmelo Carlo-Stella
-
P109: One-Day Brentuximab-Bendamustine (120mg/m2) every 21 days is a feasible and safe treatment for relapsed/refractory Hodgkin lymphoma
View full abstract at Hemasphere…
- Hannah Moatti
- Marie-Céleste Laroque
- Loïc Renaud
- Odonchimeg Ravdan
- Charlotte Schmidt-Hieber
- Isabelle Madelaine
- Roberta Di Blasi
- Catherine Thieblemont
- Pauline Brice
-
P110: Outcome of high-dose chemotherapy (HDCT) and autologous stem cell transplant (ASCT) as first salvage treatment for relapsed or refractory classical Hodgkin Lymphoma (cHL) in the era of PET-adapted strategy among Italian centers
View full abstract at Hemasphere…
- Simonetta Viviani
- Anna Vanazzi
- Samuele Frassoni
- Chiara Rusconi
- Andrea Rossi
- Alessandra Romano
- Caterina Patti
- Corrado Schiavotto
- Roberto Sorasio
- Vincenzo Marasco
- Laura Lissandrini
- Davide Rapezzi
- Daniela Gottardi
- Federica Cocito
- Antonino Mulè
- Guido Gini
- Roberta Zanotti
- Alessandro Rambaldi
- Vincenzo Bagnardi
- Corrado Tarella
-
P111: Phase I Trial of Brentuximab Vedotin plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma
View full abstract at Hemasphere…
- Swetha Kambhampati
- Matthew Mei
- Lu Chen
- Sandrine Puvurel
- Robert Chen
- Leslie Popplewell
- Liana Nikolaenko
- Lacolle Peters
- Saro Armenian
- Larry Kwak
- Steven T. Rosen
- Stephen Forman
- Alex F. Herrera
-
P112: Phase II Trial of Brentuximab Vedotin plus ibrutinib in Relapsed/Refractory Hodgkin Lymphoma
View full abstract at Hemasphere…
- Matthew Mei
- Joycelynne Palmer
- Kami Maddocks
- Peter Martin
- Ni-Chun Tsai
- Eileen Smith
- Leslie Popplewell
- Saro Armenian
- Geoffrey Shouse
- Robert Chen
- Larry Kwak
- Steven T. Rosen
- Stephen Forman
- David Bond
- Alex F. Herrera
-
P113: Promising results with anti-PD-1 therapy in primary refractory Hodgkin lymphoma: a single-centre report
View full abstract at Hemasphere…
- Caterina Zerbi
- Tanja Lazic
- Roberta Sciarra
- Caterina Cristinelli
- Alessandro Mazzacane
- Federico Carpi
- Virginia Valeria Ferretti
- Giulia Gambini
- Maurizio Bonfichi
- Luca Arcaini
- Manuel Gotti
-
P114: Very late relapses in patients with Hodgkin Lymphoma occuring ≥5 years after initial treament with chemotherapy ± radiotherapy: Treatment strategies and prognostic factors for the outcome
View full abstract at Hemasphere…
- Theodoros P. Vassilakopoulos
- Athanasios Liaskas
- Giuliana Rizzuto
- Argyrios Symeonidis
- Marzia Palma
- Maria K. Angelopoulou
- Chara Giatra
- Flora Kondopidou
- Maria Dimou
- Alberto Musseti
- Ioanna Xagoraris
- Marina Siakantaris
- Evgenia Verigou
- Fotios Panitsas
- John Asimakopoulos
- Maria Arapaki
- Chrysovalantou Chatzidimitriou
- Marina Belia
- Sotirios Sachanas
- Penelope Korkolopoulou
- Antonello Cabras
- Eleni Variamis
- Panayiotis Panayiotidis
- Maria Bakiri
- Themistoklis Karmiris
- Georgios Z. Rassidakis
- Paolo C
Pediatric HL
-
P086: Advancing Pediatric Hodgkin Lymphoma Research Through NODAL
View full abstract at Hemasphere…
- Jamie E. Flerlage
- Suzi Birz
- Sharon M. Castellino
- Burton Appel
- Brian Furner
- Luca Graglia
- Tara O. Henderson
- David Hodgson
- Bradford S. Hoppe
- Justine Kahn
- Frank G. Keller
- Sandy Kessel
- Chen Li
- Mei Li
- John Lucas
- Kathleen McCarten
- Monika Metzger
- Sarah Milgrom
- Susan K. Parsons
- Qinglin Pei
- Yue Wu
- Yiwang Zhou
- Michael Watkins
- Sam Volchenbaum
- Kara M. Kelly
-
P088: Case series of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Tanzania. A common entity in East Africa?
View full abstract at Hemasphere…
- Atukuzwe Kahakwa
- Elifuraha Mkwizu
- Alex Mremi
- Priscus Mapendo
- Oliver Henke
-
P089: Pembrolizumab in Pediatric and Young Adults Patients With Newly Diagnosed Classical Hodgkin Lymphoma and Slow Early Responders to Frontline Chemotherapy: The Phase 2 KEYNOTE-667 Study
View full abstract at Hemasphere…
- Luciana Vinti
- Stephen Daw
- Constantino Sabado Alvarez
- Franca Fagioli
- Auke Beishuizen
- Gerard Michel
- Maria Luisa Moleti
- Michaela Cepelova
- Anne Thorwarth
- Charlotte Rigaud
- Diego Plaza Lopez de Sabando
- Judith Landman Parker
- Ying Zhu
- Pallavi Pillai
- Akash Nahar
- Christine Mauz-Koerholz
-
P090: Staging of Lung Lesions Survey Demonstrates Continued Need for Harmonization
View full abstract at Hemasphere…
- Jennifer Seelisch
- Sue C. Kaste
- Kara M. Kelly
- Lars Kurch
- Michael P. Link
- Christine Mauz-Koerholz
- Kathleen McCarten
- Angela Punnett
- Dietrich Stroevesandt
- Jamie E. Flerlage
-
T087: Brentuximab vedotin (Bv) Demonstrates Superior Event-Free Survival in Pediatric High-Risk Hodgkin Lymphoma
View full abstract at Hemasphere…
- Sharon M. Castellino
- Qinglin Pei
- Susan K. Parsons
- David Hodgson
- Kathleen McCarten
- Terzah Horton
- Steve Cho
- Yue Wu
- Angela Punnett
- Hema Dave
- Tara O. Henderson
- Bradford S. Hoppe
- Ann-Marie Charpentier
- Frank G. Keller
- Kara M. Kelly
Radiotherapy
-
P091: Early analysis of the PRO-Hodgkin study: Clinical investigation of pencil beam scanning proton treatment in Hodgkin lymphoma patients.
View full abstract at Hemasphere…
- Christina Goldkuhl
- Alexandru Dasu
- Anna Bäck
- Gunilla Enblad
- Ingrid Glimelius
- Annika Hall
- Lotta Hansson
- Urban Jerlström
- Ann-Sofie Johansson
- Jenny Kahlmeter-Brandell
- Johan Linderoth
- Marzia Palma
- Hillevi Rylander
- Marika Enmark
- Daniel Molin
-
P092: Estimating the dosimetric benefit of involved-node radiotherapy in comparison to involved-field radiotherapy - implications from the GHSG HD 17 trial
View full abstract at Hemasphere…
- Michael Oertel
- Dominik Hering
- Nina Nacke
- Christopher Kittel
- Kai Kröger
- Jan Kriz
- Michael Fuchs
- Christian Baues
- Dirk Vordermark
- Rita Engenhart-Cabillic
- Klaus Herfarth
- Peter Lukas
- Heinz Schmidberger
- Simone Marnitz
- Peter Borchmann
- Andreas Engert
- Uwe Haverkamp
- Hans Theodor Eich
-
P093: From involved- field to involved-node – Quality analysis of the radiation therapy in HD 17 by the expert panel of the German Hodgkin Study Group
View full abstract at Hemasphere…
- Michael Oertel
- Dominik Hering
- Nina Nacke
- Christopher Kittel
- Kai Kröger
- Jan Kriz
- Michael Fuchs
- Christian Baues
- Dirk Vordermark
- Rita Engenhart-Cabillic
- Klaus Herfarth
- Peter Lukas
- Heinz Schmidberger
- Simone Marnitz
- Peter Borchmann
- Andreas Engert
- Uwe Haverkamp
- Hans Theodor Eich
-
P094: Long-term outcomes of bulky classic Hodgkin lymphoma managed with a PET-adapted approach demonstrate excellent outcomes in PET-negative cases
View full abstract at Hemasphere…
- Jowon Laura Kim
- Diego Villa
- R. Petter Tonseth
- Alina S. Gerrie
- Don Wilson
- Francois Benard
- Chris Venner
- Brian Skinnider
- Pedro Farinha
- Graham W. Slack
- David W. Scott
- Joseph M. Connors
- Laurie H. Sehn
- Kerry J. Savage
-
P095: Personalised Modelling of Quality-Adjusted Survival Benefit and Cost-Effectiveness of using Proton Beam Therapy inthe Treatment of Intermediate-Stage Hodgkin Lymphoma in England
View full abstract at Hemasphere…
- David Jones
- Rebecca Shakir
- Paolo Candio
- Johanna Ramroth
- Jane Wolstenholme
- Alastair Gray
- David Cutter
- Georgios Ntentas
-
P096: Polymorphisms in SETD7 may predispose the risk of developing late cardiac side effects after radiotherapy including the mediastinum in Hodgkin´s lymphoma.
View full abstract at Hemasphere…
- Johan Linderoth
- Eva Freyhult
- Ellinor Andreasson
- Ann-sofie Johansson
- Anne Andersson
- Ingrid Glimelius
- Gunilla Enblad
- Daniel Molin
-
P097: The status quo of involved-field radiotherapy – Quality analysis of radiotherapy in the GHSG HD 16
View full abstract at Hemasphere…
- Michael Oertel
- Dominik Hering
- Christopher Kittel
- Nina Nacke
- Kai Kröger
- Jan Kriz
- Michael Fuchs
- Christian Baues
- Dirk Vordermark
- Rita Engenhart-Cabillic
- Klaus Herfarth
- Peter Lukas
- Heinz Schmidberger
- Simone Marnitz
- Peter Borchmann
- Uwe Haverkamp
- Andreas Engert
- Hans Theodor Eich
Categories
ISHL12 Award Winners
Poster Award
- Lilian Beeck (P043)
- Julia Driessen (P107)
- David Jones (P095)
- Laman Mammadova (P037)
- Andrea Visentin (P054)
Karl Musshoff Prize: Best Clinical Abstract
Alison Moskowitz
T099: High efficacy and durability of second-line therapy with pembrolizumab, gemcitabine, vinorelbine, and liposomal doxorubicin in the phase II study for relapsed and refractory Hodgkin lymphoma
Karl Musshoff Prize: Best Preclinical Abstract
Julia Paczkowska
T028: Single-cell RNA sequencing reveals the interplay between circulating CD4 T cells, B cells and cancer-associated monocytes in classic Hodgkin lymphoma treated with PD-1 blockade